Results 151 to 160 of about 39,256 (202)

Predicting surgical outcome in drug-resistant epilepsy by combining interictal biomarkers within a machine learning framework. [PDF]

Sci Rep
Partamian H, Jahromi S, Perry MS, Hansen D, Bosemani M, Wang J, Tamilia E, Madsen JR, Bolton J, Stone SSD, Pearl PL, Papadelis C.   +11 more
europepmc   +1 more source

Clobazam in Adult Drug-Resistant Epilepsy: Excellent Long-Term Retention and Potential Synergy with Neuromodulation. [PDF]

Cureus
Fang B, Haroon M, Kalantzis E, Kurukumbi M.   +3 more
europepmc   +1 more source

Real-World Use of Cenobamate in Paediatric Drug-Resistant Epilepsy: Long-Term Efficacy, Safety, and Co-Medication Adjustment. [PDF]

Eur J Neurol
Pisano T, Pisano T, Balestrini S, Boncristiano A, Caini S, Lombardini M, Scuma E, Cavallin M, Bartolini L, Pellacani S, Barba C, Guerrini R.   +11 more
europepmc   +1 more source

Transcriptomic decoding of regional cortical vulnerability to drug-resistant epilepsy using 7T MRI. [PDF]

Commun Biol
Mao H, Matsubara T, Tanaka N, Peled N, Farzaneh H, Melania Lon D, Suzuki N, Richardson RM, Cole AJ, Fang X, Stufflebeam SM.   +10 more
europepmc   +1 more source

A structured narrative review on VNS-treated drug-resistant epilepsy: EEG markers, neurochemical mechanisms, and future biomarker-driven computational directions. [PDF]

Front Neurosci
Muroni A, Bhat KM, Maleci A, Marrosu F.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug resistance in epilepsy

The Lancet Neurology, 2023
Drug resistance is estimated to affect about a third of individuals with epilepsy, but its prevalence differs in relation to the epilepsy syndrome, the cause of epilepsy, and other factors such as age of seizure onset and presence of associated neurological deficits.
Emilio Perucca, Piero Perucca, H Steve White, Elaine C Wirrell   +3 more
openaire   +2 more sources

Drug-Resistant Epilepsy

New England Journal of Medicine, 2011
Nearly a quarter of patients with seizures have drug-resistant epilepsy. This review examines how this diagnosis should be established and how to recognize pseudoresistance. It explains possible mechanisms of drug-resistant epilepsy and presents treatment strategies.
Katsuhiro, Kobayashi, Harumi, Yoshinaga, Yoko, Ohtsuka   +2 more
openaire   +6 more sources

Mechanisms of Apoptosis in Drug-Resistant Epilepsy

Neuroscience and Behavioral Physiology, 2022
Epilepsy is a chronic neurological disease with regular spontaneous seizures associated with neuroinflammatory, autoimmune and neurodegenerative processes. Approximately 40% of patients suffer from drug-resistant epilepsy, which leads to an increased risk of premature death, injury, irreversible brain damage, psychosocial dysfunction, and reduced ...
E.D. Bazhanova, A.A. Kozlov
openaire   +2 more sources

Topiramate for drug-resistant epilepsies

European Journal of Paediatric Neurology, 2000
Topiramate is a new anti-epileptic drug with proven efficacy against partial seizures in adults. A retrospective assessment of the use of topiramate in drug-resistant childhood epilepsy was undertaken. Thirty-four children (median age of 10 years; range 2-18 years) were treated for a median of 9 months (range 6-18 months).
S, Yeung, C D, Ferrie, D G, Murdoch-Eaton, J H, Livingston   +3 more
openaire   +2 more sources

Ciprofloxacin for treatment of drug-resistant epilepsy

Epilepsy Research, 2021
To investigate the efficacy of short-term treatment with ciprofloxacin in alteration of gut microbiota pattern and reduction of seizure frequency in adult patients with drug-resistant epilepsy.In a prospective study, we investigated the effect of a 5-day course of treatment with ciprofloxacin on gut microbiota pattern and seizure frequency of 23 adults
Hamed Cheraghmakani, Mohammad Sadegh Rezai, Reza Valadan, Golnar Rahimzadeh, Mona Moradi, Vahid Jahanfekr, Mahmood Moosazadeh, Nasim Tabrizi   +7 more
openaire   +2 more sources